Parving HH - Search Results

1

Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy.

Bos H, Andersen S, Rossing P, De Zeeuw D, Parving HH, De Jong PE, Navis G. Bos H, et al. Among authors: parving hh. Kidney Int Suppl. 2000 Apr;75:S32-7. Kidney Int Suppl. 2000. PMID: 10828759 Free article.

2

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.

Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH. Andersen S, et al. Among authors: parving hh. Kidney Int. 2000 Feb;57(2):601-6. doi: 10.1046/j.1523-1755.2000.00880.x. Kidney Int. 2000. PMID: 10652037 Free article. Clinical Trial.

3

Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy.

Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Tarnow L, Rossing P, Parving HH. Schjoedt KJ, et al. Among authors: parving hh. Kidney Int. 2006 Aug;70(3):536-42. doi: 10.1038/sj.ki.5001580. Epub 2006 Jun 14. Kidney Int. 2006. PMID: 16775595 Free article. Clinical Trial.

4

Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.

Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving HH. Hansen HP, et al. Among authors: parving hh. Kidney Int. 1995 Jun;47(6):1726-31. doi: 10.1038/ki.1995.238. Kidney Int. 1995. PMID: 7643542 Free article. Clinical Trial.

5

The use of antihypertensive agents in prevention and treatment of diabetic nephropathy.

Parving HH, Rossing P. Parving HH, et al. Curr Opin Nephrol Hypertens. 1994 May;3(3):292-300. doi: 10.1097/00041552-199405000-00010. Curr Opin Nephrol Hypertens. 1994. PMID: 7922255 Review.

6

Calcium antagonists and the diabetic hypertensive patient.

Parving HH, Rossing P. Parving HH, et al. Am J Kidney Dis. 1993 Jun;21(6 Suppl 3):47-52. doi: 10.1016/0272-6386(93)70124-h. Am J Kidney Dis. 1993. PMID: 8503435 Review.

7

Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.

Jacobsen P, Rossing K, Rossing P, Tarnow L, Mallet C, Poirier O, Cambien F, Parving HH. Jacobsen P, et al. Among authors: parving hh. Kidney Int. 1998 Apr;53(4):1002-6. doi: 10.1111/j.1523-1755.1998.00847.x. Kidney Int. 1998. PMID: 9551410 Free article.

8

Glomerular permselectivity in early stages of overt diabetic nephropathy.

Andersen S, Blouch K, Bialek J, Deckert M, Parving HH, Myers BD. Andersen S, et al. Among authors: parving hh. Kidney Int. 2000 Nov;58(5):2129-37. doi: 10.1111/j.1523-1755.2000.00386.x. Kidney Int. 2000. PMID: 11044234 Free article. Clinical Trial.

9

Progression of diabetic nephropathy.

Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Hovind P, et al. Among authors: parving hh. Kidney Int. 2001 Feb;59(2):702-9. doi: 10.1046/j.1523-1755.2001.059002702.x. Kidney Int. 2001. PMID: 11168952 Free article.

10

Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.

Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Hovind P, et al. Among authors: parving hh. Kidney Int. 2001 Jul;60(1):277-83. doi: 10.1046/j.1523-1755.2001.00797.x. Kidney Int. 2001. PMID: 11422762 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

669 results

Search Page

Filters